Trial
NCT04141904
Tofacitinib in Depression (TIDE)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Oxford
Collaborators
Wellcome Trust; Medical Research Council
Condition
Depression
Intervention
Tofacitinib 5 MG [Xeljanz]
Why stopped
Covid-19 pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-09